Multimodal cancer treatment: Real time monitoring, optimization, and synergistic effects

Technology in Cancer Research and Treatment

Volumn 7, Issue 5, 2008, Pages 409-414

  Myhr, Gunnar ^a  

^a CancerCure Technology Ltd   (Norway)

Author keywords

Cancer treatment; Drug release; MRI monitoring; Multi Modality; Optimization

Indexed keywords

DOXORUBICIN; LIPOSOME; NANOPARTICLE;

BODY FLUID; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL DEATH; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG UPTAKE; HUMAN; HYPERTHERMIA; HYPOXIA; IONIZING RADIATION; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; NANOENCAPSULATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OXYGEN TENSION; RECURRENCE RISK; SOLID TUMOR; TISSUE OXYGENATION; VASCULARIZATION;

EID: 53549126644     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700510     Document Type: Note

References (40)

1. Saif, M. W. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer 6, 46-51 (2006).
2. Cairns, R., Papandreou, I., Denko, N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4, 61-70 (2006).
3. Haley, B., Frenkel, E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol 26, 57-64 (2008).
4. Fenske, D. B., Chonn, A., Cullis, P. R. Liposomal nanomedicines: an emerging field. Toxicol Pathol 36, 21-29 (2008).
5. Gabizon, A. A., Shmeeda, H., Zalipsky, S. Pros and cons of the liposome platform in cancer drug targeting. J Liposome Res 16, 175-183 (2006).
6. Myhr, G. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach. Med Hypotheses 70, 665-670 (2008).
7. Myhr, G. MR guided cancer treatment system. PCT/GB2008/002059, (2008).
8. Faneyte, I. F., Kristel, P. M., van de Vijver, M. J. Determining MDR1/P-glycoprotein expression in breast cancer. Int J Cancer 93, 114-122 (2001).
9. Vasir, J. K., Labhasetwar, V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 4, 363-374 (2005).
10. Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Crateri, P., Toccacieli, L., Marra, M., Colone, M., Cianfriglia, M., Arancia, G. Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells. Curr Protein Pept Sci 3, 653-670 (2002).
11. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature. The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41, 189-207 (2001).
12. Hilgenbrink, A. R., Low, P. S. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 94, 2135-2146 (2005).
13. Andresen, T. L, Jensen, S. S., Jørgensen, K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44, 68-97 (2005).
14. Arap, W., Pasqualini, R., Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380 (1998).
15. Ishida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., Allen, T. M. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochem Biophys Acta 1515, 144-158 (2001).
16. Needham, D., Dewhirst, M. W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 53, 285-305 (2001).
17. Ponce, A. M., Vujaskovic, Z., Yuan, F., Needham, D., Dewhirst, M. W. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22, 205-213 (2006).
18. Zamboni, W. C. Concept and clinical evaluation of carrier-mediated anticancer agents. The Oncologist 13, 248-260 (2008).
19. Zhang, H., Yee, D., Wang, C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomed 3, 83-93 (2008).
20. Vaupel, P., Kallinowski, F. Physiological effects of hyperthermia. In: Resent results in cancer research. Vol. 104, pp 71-109. Ed., Streffer, C. Heidelberg, Berlin: Springer-Verlag (1987).
21. Crokart, N., Radermacher, K., Jordan, B. F., Baudelet, C., Cron, G. O., Grégoire, V., Beghein, N., Bouzin, C., Feron, O., Gallez, B. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Res 65, 7911-7916 (2005).
22. Griffin, R. J., Ogawa, A., Williams, B. W., Song, C. W. Hyperthermic enhancement of tumor radiosensitization strategies. Immunol Invest 34, 343-359 (2005).
23. Liu, P., Zhang, A., Xu, Y., Xu, L. X. Study of non-uniform nanoparticle liposome extravasation in tumor. Int J Hyperthermia 21, 259-270 (2005).
24. Davies, Cde., L., Lundstrøm, L. M., Frengen, J., Eikenes, L., Bruland, S. Ø. S., Kaalhus, O., Hjelstuen, M. H., Brekken, C. Radiation improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts. Cancer Res 64, 547-553 (2004).
25. Laurand, A., Laroche-Clary, A., Larrue, A., Huet, S., Soma, E., Bonnet, J., Robert, J. Quantification of the expression of multidrug resistance-related genes in human tumor cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres. Anticancer Res 6, 3781-3788 (2004).
26. Kobayashi, T., Ishida, T., Okada, Y., Ise, S., Harashima, H., Kiwada, H. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 329, 94-102 (2007)
27. Cho, C. W., Liu, Y., Cobb, W. N., Henthorn, T. K., Lillehei, K., Christians, U., Ng, K. Y. Ultrasound-induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells. Pharm Res 19, 1123-1129 (2002).
28. Liu, Y., Cho, C. W., Yan, X., Henthorn, T. K., Lillehei, K. O., Cobb, W. N., Ng, K. Y. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells. Pharm Res 18, 1255-1261 (2001).
29. Olsrud, J., Brockstedt, S., Nilsson, A. M., Tranberg, K. G., Ståhlberg, F., Persson, B. R. MRI Thermometry in phantoms by use of the proton resonance frequency shift method: application to interstitial laser thermotherapy. Phys Med Biol 43, 2597-2613 (1998).
30. Ong, J. T., d'Arcy, J. A., Collins, D. J., Rivens, I. H., ter Haar, G. R., Leach, M. O. Sliding window dual gradient echo (SW-dGRE): T1 and proton resonance frequency (PRF) calibration for temperature imaging in polyacrylamide gel. Phys Med Biol 48, 1917-1931 (2003).
31. Zaharchuk, G., Busse, R. F., Rosenthal, G., Manley, G. T., Glenn, O. A., Dillon, W. P. Noninvasive oxygen partial pressure measurement of human body fluids in vivo using magnetic resonance imaging. Acad Radiol 13, 1016-1024 (2006).
32. Myhr, G. Multimodal ultrasound mediated drug release model in local cancer therapy. Med Hypotheses 69, 1325-1333 (2007).
33. Myhr, G. Ultrasound treatment system. PCT/GB2006/002014 (2006).
34. Myhr, G., Moan, J. Synergistic effects of chemotherapy and ultrasound treatment. Cancer Letters 232, 206-213 (2006).
35. Gabizon, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A., Siegal, T. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev 24, 337-344 (1997).
36. Husseini, G. A., Pitt, W. G. The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol 8, 2205-2215 (2008).
37. Emens, L. A. Cancer vaccines: on the threshold of success. Expert Opin Emerg Drugs 13, 295-308 (2008).
38. Zitvogel, L., Apetoh, L., Ghiringhelli, F., André, F., Tesniere, A., Kroemer, G. The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118, 1991-2001 (2008).
39. Glade-Bender, J., Kandel, J. J., Yamashiro, D. J. VEGF blocking therapy in the treatment of cancer. Expert Opin Biol Ther 3, 263-276 (2003).
40. Goh, P. P., Sze, D.M., Roufogalis, B. D. Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets 7, 743-758 (2007).